Tüdőrák: vizsgálatok itt: Egyesült Államok

In Egyesült Államok 901 Also abroad 2733

901 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

No phaseTaking people
Detection of Genetic Markers of Lung Cancer
Where
Pittsburgh
Életkor
18 év and over
People
6000
Run by
University of Pittsburgh
See details and how to joinNCT00280202
1. fázisTaking people
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Where
Houston
Életkor
12 év to 50 év
People
44
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT03093909
4. fázisTaking people
Dabrafenib and/or Trametinib Rollover Study
Where
Bethesda, Columbus, Dallas, Scottsdale
Életkor
18 év to 100 év
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
2. fázisTaking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Boston, Grand Rapids, Houston, Los Angeles, Nashville, New Haven, Newton, Trumbull
Életkor
18 év and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
1. fázisTaking people
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Where
Bethesda
Életkor
18 év to 120 év
People
30
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06066138
3. fázisTaking people
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Where
Annapolis, Auburn, Barrington, Birmingham, Cary, Dallas, Edinburg, Elmhurst, Fort Wayne, Fullerton, Gig Harbor, Goodyear, Houston, Indianapolis, Jacksonville, Kansas City, Lee's Summit, Naperville, New Hyde Park, Newport Beach, New York, Ocala, Overland, Philadelphia, Pittsburgh, Puyallup, Richardson, Rochester, Sacramento, San Antonio, Shirley, Spokane, Tacoma, Tampa, The Bronx, Westwood, Zion
Életkor
18 év and over
People
734 worldwide
Run by
NovoCure GmbH
See details and how to joinNCT06216301
3. fázisTaking people
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Where
Albany, Atlanta, Baton Rouge, Beverly Hills, Bluffton, Charleston, Columbus, Edgewood, Elmhurst, Evanston, Fargo, Fort Wayne, Hershey, Houston, Ithaca, Jacksonville, Knoxville, Lafayette, Lancaster, Lisle, Little Rock, Los Angeles, Miami Beach, Minneapolis, Morristown, Naperville, Newnan, Newport Beach, Oklahoma City, Orange, Orange City, Portland, Reno, Rochester, Salt Lake City, San Francisco, Savannah, Sioux Falls, Springdale, Stamford, St Louis, Stony Brook, Thomasville, Westbrook, White Plains
Életkor
18 év and over
People
780 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06312137 · EU 2023-508012-35-00
3. fázisTaking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Albany, Bakersfield, Beverly Hills, Billings, Cincinnati, Houston, Kansas City, Kettering, Lancaster, Madison, Miami Beach, Morristown, Skokie, Springfield, Stamford
Életkor
18 év and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
3. fázisTaking people
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Where
Albuquerque, Austin, Bismarck, Cincinnati, Daphne, Durham, Edmonds, Fargo, Fort Myers, Hot Springs, Marietta, Minneapolis, Nashville, Orange City, Peoria, Roanoke, Seattle, Sioux Falls, St. Petersburg, Tyler
Életkor
18 év and over
People
530 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06646276 · EU 2024-515740-23-00
2. fázisTaking people
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Where
Austin, Cleveland, Fairfax, Manahawkin, Pittsburgh, Weston
Életkor
18 év and over
People
40 worldwide
Run by
Wayshine Biopharm, Inc.
See details and how to joinNCT06868485
1/2. fázisTaking people
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Where
Ann Arbor, Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, Philadelphia, Salt Lake City, Seattle, St Louis
Életkor
18 év and over
People
616 worldwide
Run by
Verastem, Inc.
See details and how to joinNCT07020221
3. fázisTaking people
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Where
Canton, East Syracuse, Fort Worth, Hialeah, Hinsdale, Los Angeles, Miami, Plantation, Tamarac, Wilson
Életkor
18 év and over
People
420 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07099898
3. fázisTaking people
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Where
Albany, Bend, Beverly Hills, Birmingham, Farmington, Fort Lauderdale, Fredericksburg, Hackensack, Lafayette, Lancaster, Miami Beach, Midlothian, Minneapolis, Morgantown, Roanoke, Rochester, Savannah, Stamford, Westbrook
Életkor
18 év and over
People
675 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07190248 · EU 2024-514500-14-00
2. fázisTaking people
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Where
Clermont, Fargo, Sioux Falls
Életkor
18 év and over
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00
3. fázisTaking people
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Where
Albuquerque, Austin, Baltimore, Boston, Brandywine, Bridgeton, Chandler, Charlottesville, Chicago, Columbia, Denton, Detroit, Duarte, East Syracuse, Eau Claire, Fairfax, Fort Myers, Gilbert, Goodyear, Grand Junction, Greenville, Hershey, Hinsdale, Irvine, Jacksonville, La Jolla, Lancaster, Lincoln, Loma Linda, Los Angeles, Louisville, Marietta, Memphis, Morgantown, Newark, Newnan, Niles, Plano, Portland, Rochester, San Diego, South Portland, St. Petersburg, Tacoma, Tampa, Washington D.C., West Palm Beach, Wheat Ridge, Williamsburg, Zion
Életkor
18 év and over
People
400 worldwide
Run by
AstraZeneca
See details and how to joinNCT07291037 · EU 2024-520101-39-00
No phaseTaking people
A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
Where
Winston-Salem
Életkor
50 év to 77 év
People
27 000
Run by
Wake Forest University Health Sciences
See details and how to joinNCT07322367
3. fázisTaking people
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Where
Ann Arbor, Atlanta, Baltimore, Fayetteville, Hialeah, Kansas City, Little Rock, Louisville, Madison, Memphis, Mobile, Monroe, Omaha, Pikeville, Pittsburgh, Shreveport
Életkor
18 év and over
People
670 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07472517 · EU 2025-520565-51-00
1. fázisTaking people
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Where
Austin, Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Irvine, Irving, Lake Success, Nashville, New Haven, New York, Plantation, San Antonio, Sarasota, Spokane, West Valley City
Életkor
18 év and over
People
150 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00
3. fázisTaking people
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Where
Albany, Fairfax, Lincoln, Lisle, New Brunswick, Raleigh, Savannah
Életkor
18 év and over
People
310 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07554339 · EU 2025-522038-29-00
3. fázisTaking people
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
Where
Baltimore, Beaumont, Beverly Hills, Boulder, Charlotte, Chicago, Dallas, Easton, Edina, Fairfax, Fort Myers, Fullerton, La Jolla, Lebanon, Memphis, Morgantown, New Brunswick, New York, Omaha, Orlando, Ottawa, Palm Bay, Portland, Saint Paul, Salt Lake City, San Antonio, Sandusky, Seattle, Silver Spring, Sioux Falls, St Louis, St. Petersburg, The Bronx, Washington D.C., West Palm Beach, Winchester
Életkor
18 év and over
People
850 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07680790 · EU 2026-526486-21-00
2. fázisNot yet taking people in Egyesült Államok
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
Where
Charleston
Életkor
18 év to 80 év
People
38
Run by
Medical University of South Carolina
See details and how to joinNCT07720167
1/2. fázisTaking people
A Study of DS-3939a in Participants With Solid Tumors
Where
Fairfax, Fayetteville, Houston, Los Angeles, Portland, Providence, Tampa
Életkor
18 év and over
People
400 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT07739966 · EU 2026-525218-75-00
2. fázisTaking people
Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Where
Indianapolis
Életkor
18 év and over
People
10
Run by
Indiana University
See details and how to joinNCT07761910
1/2. fázisTaking people
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
Where
Boston, East Brunswick, Miami, Nashville, New York
Életkor
18 év and over
People
55 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07843940 · EU 2026-525459-99-00
1/2. fázisNot yet taking people in Egyesült Államok
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
Where
Bethesda
Életkor
18 év to 120 év
People
67
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07902921